Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -10.46%219.9M | 3.21%238.2M | 8.09%249.9M | 14.05%1B | 32.13%293.2M | 14.77%245.6M | 10.06%230.8M | -0.30%231.2M | -10.45%877.5M | -16.89%221.9M |
| Operating revenue | -10.08%202.6M | 4.65%220.5M | 13.00%230.4M | 12.61%911.2M | 37.37%271.3M | 16.55%225.3M | 6.20%210.7M | -7.32%203.9M | -13.61%809.2M | -22.31%197.5M |
| Cost of revenue | 3.88%190.3M | 1.62%188.7M | 5.68%197.1M | 4.81%775M | 6.91%219.6M | 1.50%183.2M | 11.06%185.7M | 0.05%186.5M | 0.96%739.4M | 0.15%205.4M |
| Gross profit | -52.56%29.6M | 9.76%49.5M | 18.12%52.8M | 63.50%225.8M | 346.06%73.6M | 86.27%62.4M | 6.12%45.1M | -1.76%44.7M | -44.20%138.1M | -73.34%16.5M |
| Operating expense | -27.39%17.5M | 1.27%23.9M | -2.29%17.1M | 23.43%90.6M | 9.48%25.4M | 51.57%24.1M | 51.28%23.6M | -6.42%17.5M | -2.26%73.4M | -26.11%23.2M |
| Selling and administrative expenses | -27.97%17M | 1.29%23.5M | -2.35%16.6M | 24.37%88.8M | 10.13%25M | 53.25%23.6M | 53.64%23.2M | -6.59%17M | -2.06%71.4M | -26.30%22.7M |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | 63.83%7.7M | 66.67%500K | ---- | ---- | ---- |
| -General and administrative expense | -27.97%17M | 1.29%23.5M | -2.35%16.6M | 24.37%88.8M | -38.73%25M | 120.56%23.6M | 56.76%23.2M | -2.30%17M | 1.71%71.4M | 36.91%40.8M |
| Depreciation amortization depletion | 0.00%500K | 0.00%400K | 0.00%500K | -10.00%1.8M | -20.00%400K | 0.00%500K | -20.00%400K | 0.00%500K | -9.09%2M | -16.67%500K |
| -Depreciation and amortization | 0.00%500K | 0.00%400K | 0.00%500K | -10.00%1.8M | -20.00%400K | 0.00%500K | -20.00%400K | 0.00%500K | -9.09%2M | -16.67%500K |
| Operating profit | -68.41%12.1M | 19.07%25.6M | 31.25%35.7M | 108.96%135.2M | 819.40%48.2M | 117.61%38.3M | -20.07%21.5M | 1.49%27.2M | -62.47%64.7M | -121.97%-6.7M |
| Net non-operating interest income (expenses) | -12.60%-14.3M | 23.03%-11.7M | 21.57%-12M | 0.00%-56.8M | 20.00%-13.6M | 21.60%-12.7M | -12.59%-15.2M | -51.49%-15.3M | -69.05%-56.8M | -28.79%-17M |
| Non-operating interest expense | 12.60%14.3M | -23.03%11.7M | -21.57%12M | 0.00%56.8M | -20.00%13.6M | -21.60%12.7M | 12.59%15.2M | 51.49%15.3M | 69.05%56.8M | 28.79%17M |
| Other net income (expenses) | 12.26%11.9M | 40.10%-11.8M | 1.95%26.2M | 35.39%59.3M | 42.7M | 23.26%10.6M | -213.87%-19.7M | 43.58%25.7M | -46.06%43.8M | 0 |
| Gain on sale of security | 10.78%11.3M | 68.09%-6M | 212.50%25M | -12.40%44.5M | 1,779.17%45.1M | -0.97%10.2M | -195.92%-18.8M | -56.76%8M | -38.42%50.8M | 130.77%2.4M |
| Special income (charges) | --0 | -483.33%-7M | -94.83%900K | 308.70%14.4M | 13.64%-1.9M | 105.00%100K | 55.56%-1.2M | --17.4M | -1,085.71%-6.9M | -833.33%-2.2M |
| -Less:Impairment of capital assets | --0 | --7M | --0 | -83.54%2.6M | -25.00%1.5M | --0 | --0 | --1.1M | --15.8M | --2M |
| -Less:Other special charges | ---- | ---- | ---- | 103.42%400K | ---- | ---- | ---- | ---- | ---11.7M | --500K |
| -Gain on sale of property,plant,equipment | --0 | --0 | -95.14%900K | 721.43%17.4M | --0 | 125.00%100K | 55.56%-1.2M | --18.5M | -500.00%-2.8M | 0.00%300K |
| Income before tax | -73.20%9.7M | 115.67%2.1M | 32.71%49.9M | 166.34%137.7M | 426.16%77.3M | 262.00%36.2M | -143.65%-13.4M | 8.67%37.6M | -76.50%51.7M | -334.65%-23.7M |
| Income tax | -86.15%900K | -54.31%5.3M | -62.75%1.9M | 103.47%29.3M | -45.54%6.1M | 1,400.00%6.5M | 3,000.00%11.6M | 24.39%5.1M | -51.02%14.4M | 53.42%11.2M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -70.37%8.8M | 87.20%-3.2M | 47.69%48M | 190.62%108.4M | 304.01%71.2M | 182.86%29.7M | -180.39%-25M | 6.56%32.5M | -80.43%37.3M | -1,346.43%-34.9M |
| Net income continuous operations | -70.37%8.8M | 87.20%-3.2M | 47.69%48M | 190.62%108.4M | 304.01%71.2M | 182.86%29.7M | -180.39%-25M | 6.56%32.5M | -80.43%37.3M | -1,346.43%-34.9M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -70.37%8.8M | 87.20%-3.2M | 47.69%48M | 190.62%108.4M | 304.01%71.2M | 182.86%29.7M | -180.39%-25M | 6.56%32.5M | -80.43%37.3M | -1,346.43%-34.9M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -70.37%8.8M | 87.20%-3.2M | 47.69%48M | 190.62%108.4M | 304.01%71.2M | 182.86%29.7M | -180.39%-25M | 6.56%32.5M | -80.43%37.3M | -1,346.43%-34.9M |
| Diluted earnings per share | -68.65%0.58 | 86.27%-0.21 | 58.25%3.07 | 207.83%6.68 | 317.24%4.41 | 203.28%1.85 | -184.53%-1.53 | 9.60%1.94 | -80.34%2.17 | -1,227.78%-2.03 |
| Basic earnings per share | -67.42%0.58 | 86.27%-0.21 | 55.98%2.87 | 207.83%6.68 | 317.24%4.41 | 191.80%1.78 | -191.07%-1.53 | 10.18%1.84 | -78.62%2.17 | -1,227.78%-2.03 |
| Dividend per share | 0.00%0.35 | 11.25%0.35 | 11.25%0.35 | 13.35%1.3292 | 11.25%0.35 | 22.38%0.35 | 10.00%0.3146 | 10.00%0.3146 | 4.88%1.1726 | 10.00%0.3146 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.